Pain-associated signals, acidosis and lysophosphatidic acid, modulate the neuronal K(2P)2.1 channel

Molecular and Cellular Neurosciences
Asi CohenNoam Zilberberg

Abstract

Pain is a physiological state promoting protective responses to harmful episodes. However, pain can become pathophysiological and become a chronic disruptive condition, damaging quality of life. The mammalian K(2P)2.1 (KCNK2, TREK-1) channel, expressed in sensory neurons of the dorsal root ganglia, was previously identified as a polymodal molecular sensor involved in pain perception. Here, we report that two pain-associated signals, external acidosis and lysophosphatidic acid (LPA), known to rise during injury, inflammation and cancer, profoundly down-modulate human K(2P)2.1 activity. The pH regulatory effect was mediated by activation of proton-sensitive G-protein coupled receptors and phospholipase C. Physiological concentrations of LPA overcame the effects of known K(2P)2.1 activators, such as arachidonic acid, lysophosphatidylcholine and temperature, by activating cell-surface receptors stimulating the G(q) pathway. Furthermore, we identified three K(2P)2.1 carboxy-terminal residues that mediate both pH and LPA regulatory effects. Our results highlight the important role of K(2P)2.1 channels as receptors for mediators known to cause nociception.

References

Feb 1, 1986·Journal of Neurochemistry·R von HanwehrB K Siesjö
Oct 1, 1986·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M L SmithB K Siesjö
Feb 1, 1996·Progress in Neurobiology·J W Deitmer, C R Rose
Aug 4, 1998·The EMBO Journal·A J PatelM Lazdunski
Sep 10, 1999·The Journal of Biological Chemistry·F MaingretE Honoré
Apr 1, 2000·The Journal of Biological Chemistry·F MaingretE Honoré
Apr 28, 2000·Pflügers Archiv : European journal of physiology·H J MeadowsC G Chapman
Jun 3, 2000·The EMBO Journal·F MaingretE Honoré
Feb 13, 2001·Brain Research. Molecular Brain Research·A D MedhurstM N Pangalos
Mar 21, 2001·Nature Reviews. Neuroscience·S A GoldsteinN Zilberberg
Sep 15, 2001·Nature·D Julius, A I Basbaum
May 7, 2002·Nature Reviews. Cancer·Patrick W MantyhSteve P Hunt
Sep 5, 2003·Nature·Marie-Gabrielle LudwigKlaus Seuwen
Sep 25, 2003·Physiological Reviews·Mitchell Chesler
Jun 4, 2004·The EMBO Journal·C HeurteauxM Lazdunski
Jul 24, 2004·Seminars in Cell & Developmental Biology·Saubhik SenguptaYan Xu
Dec 2, 2004·The Journal of Biological Chemistry·Jean CheminEric Honoré
Dec 4, 2004·The EMBO Journal·Jean CheminEric Honoré
Jan 29, 2005·The Journal of Physiology·Coeli M B LopesDiomedes E Logothetis
Jul 12, 2005·The Journal of Biological Chemistry·Janet MurbartiánDouglas A Bayliss
Oct 26, 2005·Biochemical Society Transactions·A L Parrill
May 6, 2006·The EMBO Journal·Abdelkrim AllouiMichel Lazdunski
Aug 15, 2006·Neuroscience Letters·Jun-Ho LaJaehee Han
Aug 15, 2006·Nature Neuroscience·Catherine HeurteauxMichel Lazdunski
Mar 22, 2007·Nature Reviews. Neuroscience·Eric Honoré
Aug 28, 2007·Molecular and Cellular Neurosciences·Chia-Wei HuangWei-Hsin Sun
Aug 31, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Stephen G BrickleyWilliam Wisden
Dec 21, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Daniel K MulkeyDouglas A Bayliss
Feb 19, 2008·Cancer Research·Iryna VoloshynaSteven J Feinmark

❮ Previous
Next ❯

Citations

May 1, 2009·European Biophysics Journal : EBJ·Asi CohenNoam Zilberberg
Nov 3, 2010·The Journal of Clinical Investigation·Adrienne E Dubin, Ardem Patapoutian
Oct 1, 2013·Journal of Physiology and Biochemistry·Ren-Gong ZhuoJian-Quan Zheng
Jan 30, 2014·Nature Neuroscience·Stephen G Waxman, Gerald W Zamponi
Nov 22, 2011·Nature Chemical Biology·Andrés Nieto-PosadasTamara Rosenbaum
Aug 28, 2012·Medical Hypotheses·Yong WeiHongli Li
Oct 20, 2009·Molecular and Cellular Neurosciences·Yifat Segal-HayounNoam Zilberberg
Nov 26, 2014·Pflügers Archiv : European journal of physiology·Alistair Mathie, Emma L Veale
Jun 28, 2018·Journal of Neurophysiology·Ileana Hernández-AraizaTamara Rosenbaum
Oct 31, 2018·Molecular Omics·H StarobovaI Vetter
Apr 16, 2010·The Journal of Pharmacology and Experimental Therapeutics·James GierseJaime Masferrer
Dec 16, 2011·Physiology·Florian Lesage, Jacques Barhanin
Sep 24, 2019·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Luke A PattisonEwan St John Smith
Apr 23, 2015·The European Journal of Neuroscience·P Rivas-RamírezA Reboreda
Apr 15, 2015·Current Opinion in Supportive and Palliative Care·Christoforos Tsantoulas
Jan 16, 2020·International Journal of Molecular Sciences·Paula Rivas-RamírezJ Antonio Lamas
Jan 9, 2019·Frontiers in Molecular Neuroscience·Rebeca Juárez-ContrerasSara L Morales-Lázaro
Apr 10, 2019·Neural Regeneration Research·J Antonio Lamas, Diego Fernández-Fernández
May 17, 2019·International Journal of Molecular Sciences·J Antonio LamasSalvador Herrera-Pérez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.